| Literature DB >> 30946540 |
Teppei Araki1, Fumiaki Yoshida2,3,4,5, Takafumi Uemura1, Yuki Noda1, Shusuke Yoshimoto1, Taro Kaiju3, Takafumi Suzuki3, Hiroki Hamanaka2,3, Kousuke Baba6, Hideki Hayakawa6, Taiki Yabumoto6, Hideki Mochizuki6, Shingo Kobayashi7, Masaru Tanaka7, Masayuki Hirata2,3, Tsuyoshi Sekitani1.
Abstract
Neural interfaces enabling light transmittance rely on optogenetics to control and monitor specific neural activity, thereby facilitating deeper understanding of intractable diseases. This study reports the material strategy underlying an optogenetic neural interface comprising stretchable and transparent conductive tracks and capable of demonstrating high biocompatibility after long-term (5-month) implantation. Ag/Au core-shell nanowires contribute toward improving track performance in terms of stretchability (<60% strain), transparency (<83%), and electrical resistance (15 Ω sq-1 ). The neural interface integrated with gel-coated exterior microelectrodes preserves low impedance (1.1-3.2 Ω cm2 ) in a saline solution over the evaluated 5-month period. Besides the use of efficient conductive materials, surface treatment using antithrombogenic polymer tends to prevent the growth of granulation tissue, thereby facilitating clear monitoring of electrocorticograms (ECoG) in a rodent during chronic implantation. The flexible and transparent neural interface pathologically exhibits noncytotoxicity and low inflammatory response while efficiently recording evoked ECoG in a nonhuman primate via optogenetic stimulation. The proposed highly reliable interface can be employed in multifaceted approaches for translational research based on chronic implants.Entities:
Keywords: electrocorticograms; flexible electronics; nanowires; optogenetics; transparent electrodes
Mesh:
Substances:
Year: 2019 PMID: 30946540 DOI: 10.1002/adhm.201900130
Source DB: PubMed Journal: Adv Healthc Mater ISSN: 2192-2640 Impact factor: 9.933